Ovarian cancer affects approximately 3000 women per year in Canada. Although most cases are sporadic, there are hereditary forms of ovarian cancer that are largely attributed to mutations in the
The development and implementation of the new Canadian SARS-CoV-2 Data Portal will be led by McGill University’s Dr. Guillaume Bourque, Professor in the Department of Human Genetics, and Director, Canadian Center
Experts across Canada, including researchers at McGill, are working to understand the impact of COVID-19 virus variants of concern on the health of Canadians and our public health measures. Today,
https://montreal.ctvnews.ca/all-hands-on-deck-montreal-scientists-step-up-in-urgent-covid-19-variant-hunt-1.5307833
Joint research program between the Japan Agency for Medical Research and Development and the Canadian Institutes of Health Research focuses on advancing technologies in epigenomics, deepening McGill’s relationship with Japan’s
Today the Institut national de santé publique du Québec (INSPQ) and the McGill Genome Centre announced the initial results of their study into the genetic sequencing of the SARS-CoV-2 genome,
Face à la pandémie de COVID-19, deux biobanques ont rapidement été mises sur pied pour faciliter la recherche. Comment en apprendre davantage sur le virus SARS-CoV-2 et ses impacts sur
Partnership will support efforts to sequence and analyze the spread and evolution of the SARS-CoV-2 virus and how it affects patients Over the last weeks, the McGill Genome Centre has established a
COG-UK and CanCOGeN are working together to share knowledge and protocols The COVID-19 Genomics UK (COG-UK) consortium is collaborating with the newly formed Canadian COVID Genomics Network (CanCOGeN) as it launches a
McGill’s SSHRC Institutional Grant and MI4 co-fund 12 projects exploring the social dimension of the COVID-19 pandemic. Twelve McGill researchers are the recipients of a total of $179,258 in one-time